Chongqing Pharmaceutical Industrial Research Institute Co. Ltd.
发明人:
申请号：
EP15871510.2
公开号：
EP3239149A4
申请日:
2015.03.27
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Disclosed in the present invention is a crystal form I of Canagliflozin, and an X-ray powder diffraction spectrum of the crystal form I has characteristic diffraction peaks when 2¸ is at the position of 4.4±0.2°, 8.4±0.2°, 16.8±0.2°, 17.5±0.2°, 18.0±0.2°, and 22.8±0.2°. The crystal form is physically and chemically stable and is suitable for manufacturing of various preparations.
